Disease/Infection News

RSS
Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

Onset and prognosis of post-COVID-19 condition: A 2-Year observational study

In move to slash CDC budget, House Republicans target major HIV program Trump launched

In move to slash CDC budget, House Republicans target major HIV program Trump launched

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Global case series uncovers Mpox resurgence among previously infected or fully vaccinated individuals

Is there an association between the COVID-19 pandemic and cancer incidence?

Is there an association between the COVID-19 pandemic and cancer incidence?

Wearable technology emerges as a potential game-changer in early detection of COVID-19 among athletes

Wearable technology emerges as a potential game-changer in early detection of COVID-19 among athletes

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Hepatitis C patients may benefit from revaccination against hepatitis B after treatment

Blood clots may be a cause of long-term cognitive problems after COVID-19

Blood clots may be a cause of long-term cognitive problems after COVID-19

Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study

Chronic inflammation's influence on TP53 mutations in leukemia evolution explored in new study

Specialized astrocyte subpopulation discovery sheds light on brain health and treatment avenues

Specialized astrocyte subpopulation discovery sheds light on brain health and treatment avenues

Novel method using DNA nanoballs could revolutionize pathogen detection

Novel method using DNA nanoballs could revolutionize pathogen detection

BA.2.86 Omicron variant: Is our immunity under siege?

BA.2.86 Omicron variant: Is our immunity under siege?

One in three men carry HPV: The ignored reservoir in the fight against cancer

One in three men carry HPV: The ignored reservoir in the fight against cancer

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Study characterizes SARS-CoV-2 Omicron BA.2.86: New variant under watch

Review identifies future research directions for the study of a SARS-CoV-2 reservoir in PASC

Review identifies future research directions for the study of a SARS-CoV-2 reservoir in PASC

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Early viral exposure in mice weakens vaccine response, raising questions for human studies

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

Monovalent vaccine outperforms bivalent in fighting new Omicron variants

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

Novavax's updated XBB.1.5 vaccine shows promising cross-neutralizing antibodies against new COVID-19 variants

Could a new framework for aging biomarkers revolutionize how we understand and treat the aging process?

Could a new framework for aging biomarkers revolutionize how we understand and treat the aging process?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.